🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, open-label study designed to evaluate the safety, effic...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT05646524
Treatments Being Tested
Vasculitis denotes affection of small to medium sized vessels by polyangiti...
Status
Unknown
Location
Assiut University Pediatric Hospital
Start Date
2018-11-11
Trial ID
NCT03692416
Treatments Being Tested
This Phase 1b basket trial will investigate the safety, tolerability, pharm...
Status
Recruiting
Location
University of California-Irvine
Start Date
2024-08-19
Trial ID
NCT06371417
Treatments Being Tested
This Phase 2 study is designed to assess the safety, efficacy, pharmacokine...
Status
Recruiting
Location
ADARx Clinical Site
Start Date
2025-08-28
Trial ID
NCT06989359
Treatments Being Tested
Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, inflammatory...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-09-03
Trial ID
NCT06673394
Treatments Being Tested
Single-chain urokinase-type plasminogen activator (pro-urokinase) is a high...
Status
Terminated
Location
Center for Human Drug Research
Start Date
2012-09
Trial ID
NCT01694381
Treatments Being Tested
This study aims to evaluate the efficacy and safety of crovalimab in pediat...
Status
Active Not Recruiting
Location
Children's Hospital Colorado
Start Date
2021-11-17
Trial ID
NCT04958265
Treatments Being Tested
This study was designed to provide continued access to BCX9930 for particip...
Status
Terminated
Location
Investigative Site
Start Date
2023-01-18
Trial ID
NCT05741346
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of ALXN172...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-11-21
Trial ID
NCT05556096
Prospective, double-blind, randomized, placebo-controlled First-In-Human st...
Status
Completed
Location
Medical University of Vienna
Start Date
2015-07-13
Trial ID
NCT02502903